<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Neuromodulation therapies &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/neuromodulation-therapies/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 28 Oct 2025 13:21:21 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Neuromodulation therapies &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Mount Sinai Receives $4.5M BD2 Grant to Propel Bipolar Disorder Biology Research</title>
		<link>https://bioengineer.org/mount-sinai-receives-4-5m-bd2-grant-to-propel-bipolar-disorder-biology-research/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 28 Oct 2025 13:21:06 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[BD2 Grant Funding]]></category>
		<category><![CDATA[Bipolar Disorder Research]]></category>
		<category><![CDATA[Brain Circuit Mapping]]></category>
		<category><![CDATA[Deep Brain Stimulation (DBS)]]></category>
		<category><![CDATA[Neuromodulation therapies]]></category>
		<guid isPermaLink="false">https://bioengineer.org/mount-sinai-receives-4-5m-bd2-grant-to-propel-bipolar-disorder-biology-research/</guid>

					<description><![CDATA[The Icahn School of Medicine at Mount Sinai has secured a significant three-year grant totaling $4.5 million from the Breakthrough Discoveries for thriving with Bipolar Disorder (BD²) initiative. This financial support aims to advance the understanding of the neural mechanisms underlying bipolar disorder and to drive the development of pioneering neuromodulation-based therapeutic strategies. The research [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">287721</post-id>	</item>
		<item>
		<title>Boosting Frontostriatal Health to Combat OCD</title>
		<link>https://bioengineer.org/boosting-frontostriatal-health-to-combat-ocd/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 11 Aug 2025 16:20:03 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Computational neuroscience]]></category>
		<category><![CDATA[Frontostriatal circuits]]></category>
		<category><![CDATA[Neuroimaging in OCD]]></category>
		<category><![CDATA[Neuromodulation therapies]]></category>
		<category><![CDATA[OCD neural dynamics]]></category>
		<guid isPermaLink="false">https://bioengineer.org/boosting-frontostriatal-health-to-combat-ocd/</guid>

					<description><![CDATA[In recent years, the intricate workings of the human brain have been a focal point for understanding complex neuropsychiatric disorders. Among these, obsessive-compulsive disorder (OCD) stands out as a debilitating condition characterized by persistent intrusive thoughts and repetitive behaviors. A groundbreaking study published in Nature Communications sheds unprecedented light on the dynamic neural mechanisms underpinning [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">255024</post-id>	</item>
	</channel>
</rss>
